LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 765 | 501 | 3148 | 0.1592 | -0.1876 |
Hs 578T | Dasatinib | 1.11 | uM | LJP6 | 72 | hr | 765 | 511 | 3101 | 0.1648 | -0.1810 |
Hs 578T | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 482 | 3148 | 0.1531 | -0.2040 |
Hs 578T | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 765 | 416 | 3101 | 0.1344 | -0.2603 |
Hs 578T | Dasatinib | 10 | uM | LJP5 | 72 | hr | 765 | 480 | 3148 | 0.1526 | -0.2040 |
Hs 578T | Dasatinib | 10 | uM | LJP6 | 72 | hr | 765 | 354 | 3101 | 0.1144 | -0.3207 |
Hs 578T | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 765 | 841 | 3148 | 0.2671 | 0.0474 |
Hs 578T | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 765 | 717 | 3148 | 0.2280 | -0.0309 |
Hs 578T | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 765 | 768 | 3148 | 0.2440 | 0.0019 |
Hs 578T | Tozasertib | 1.11 | uM | LJP5 | 72 | hr | 765 | 752 | 3148 | 0.2389 | -0.0091 |
Hs 578T | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 765 | 770 | 3148 | 0.2447 | 0.0033 |
Hs 578T | Tozasertib | 10 | uM | LJP5 | 72 | hr | 765 | 711 | 3148 | 0.2260 | -0.0353 |
Hs 578T | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 765 | 3029 | 3101 | 0.9768 | 0.9769 |
Hs 578T | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 765 | 3128 | 3101 | 1.0084 | 1.0082 |
Hs 578T | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 765 | 3138 | 3101 | 1.0117 | 1.0113 |
Hs 578T | Imatinib | 1.11 | uM | LJP6 | 72 | hr | 765 | 3275 | 3101 | 1.0558 | 1.0544 |
Hs 578T | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 765 | 3256 | 3101 | 1.0498 | 1.0487 |
Hs 578T | Imatinib | 10 | uM | LJP6 | 72 | hr | 765 | 3387 | 3101 | 1.0920 | 1.0892 |
Hs 578T | NVP-TAE684 | 0.04 | uM | LJP6 | 72 | hr | 765 | 2879 | 3101 | 0.9283 | 0.9277 |
Hs 578T | NVP-TAE684 | 0.12 | uM | LJP6 | 72 | hr | 765 | 1895 | 3101 | 0.6112 | 0.5671 |
Hs 578T | NVP-TAE684 | 0.37 | uM | LJP6 | 72 | hr | 765 | 2148 | 3101 | 0.6928 | 0.6677 |
Hs 578T | NVP-TAE684 | 1.11 | uM | LJP6 | 72 | hr | 765 | 1479 | 3101 | 0.4766 | 0.3852 |
Hs 578T | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 765 | 891 | 3101 | 0.2871 | 0.0772 |
Hs 578T | NVP-TAE684 | 10 | uM | LJP6 | 72 | hr | 765 | 531 | 3101 | 0.1713 | -0.1669 |
Hs 578T | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 765 | 2650 | 3148 | 0.8417 | 0.8378 |